Investors with an interest in Business - Services stocks have likely encountered both Concentrix Corporation (CNXC) and UL Solutions Inc. (ULS). But which of these two stocks presents investors with the better value opportunity right now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Leidos (NYSE: LDOS - Get Free Report) and Concentrix (NASDAQ: CNXC - Get Free Report) are both industrials companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends. Profitability This table compares Leidos and Concentrix's net margins, return
SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, is investigating Concentrix Corporation (NASDAQ: CNXC) on behalf of investors who may have suffered losses. If you purchased Concentrix securities and suffered losses, please contact the firm to learn more about the investigation. There is no cost or obligation.
What happened Concentrix Corporation (NASDAQ: CNXC) reported third-quarter revenue of $2.45 billion and a GAAP loss after a $1.05 billion goodwill charge. Revenue was down 1.2% from $2.48 billion a year earlier. Operating loss was $(910.3) million, and operating margin was (37.1)% versus 5.9% in the prior-year quarter. Non-GAAP operating income was $309.0 million, and
Concentrix's fiscal third-quarter revenue missed analysts' estimates. The shortfall, however, reflects a shift in paying customers' preferences rather than a loss of customers.
Concentrix Corporation reported Q3 FY26 revenue of $2.45B, down 1.2% y/y, missing estimates, and issued a $1B goodwill impairment charge. CNXC's profitability remains pressured, with operating loss of $910M, but adjusted operating margin improved 30bps to 12.6% and interest coverage is healthy at 5.5x. Q3 results disappointed, with weak segment performance and a significant cut to FY26 and Q4 revenue guidance, driving a >10% post-market share drop.